Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pollock

Showing results (571-580 of 634) with videos related to

Pageof 64
Sort By:
British Journal of Clinical Pharmacology|May 5, 2016
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitationThang Ho, Bruce G Pollock, Benoit H Mulsant, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 7, 2012
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model buildingEric A Sherer, Mark E Sale, Bruce G Pollock, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 22, 2024
The Cognitive Profile of Older Adults With Treatment-Resistant Depression: An Analysis of the OPTIMUM Randomized Controlled TrialNicholas J Ainsworth, Hanadi Oughli, Helen Lavretsky, et al.
International Journal of Geriatric Psychiatry|January 26, 2016
Amyloid deposition in semantic dementia: a positron emission tomography studyEric E Brown, Ariel Graff-Guerrero, Sylvain Houle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Journal of Alzheimer'S Disease : JAD|February 12, 2019
Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in RemissionCorinne E Fischer, Ines Kortebi, Wael K Karameh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
Neurobiology of Aging|July 3, 2026
Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adultsJessica K Hur, Jiya N Shah, Nhu Huynh, et al.
International Psychogeriatrics|March 29, 2021
Comparing cardiovascular risk factors in older persons with mild cognitive impairment and lifetime history of major depressive disorderWael K Karameh, Ines Kortebi, Sanjeev Kumar, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
Pageof 64

Showing results (571-580 of 634) with videos related to

Sort By:
Pageof 64
British Journal of Clinical Pharmacology|May 5, 2016
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitationThang Ho, Bruce G Pollock, Benoit H Mulsant, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 7, 2012
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model buildingEric A Sherer, Mark E Sale, Bruce G Pollock, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 22, 2024
The Cognitive Profile of Older Adults With Treatment-Resistant Depression: An Analysis of the OPTIMUM Randomized Controlled TrialNicholas J Ainsworth, Hanadi Oughli, Helen Lavretsky, et al.
International Journal of Geriatric Psychiatry|January 26, 2016
Amyloid deposition in semantic dementia: a positron emission tomography studyEric E Brown, Ariel Graff-Guerrero, Sylvain Houle, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Journal of Alzheimer'S Disease : JAD|February 12, 2019
Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in RemissionCorinne E Fischer, Ines Kortebi, Wael K Karameh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
Neurobiology of Aging|July 3, 2026
Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adultsJessica K Hur, Jiya N Shah, Nhu Huynh, et al.
International Psychogeriatrics|March 29, 2021
Comparing cardiovascular risk factors in older persons with mild cognitive impairment and lifetime history of major depressive disorderWael K Karameh, Ines Kortebi, Sanjeev Kumar, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
Pageof 64